Evidence map›Paper›PMID 30510209›Full record

ArticleScientific reports2018

Complex role of miR-130a-3p and miR-148a-3p balance on drug resistance and tumor biology in esophageal squamous cell carcinoma.

A K Eichelmann, C Matuszcak, K Lindner, J Haier, D J Hussey, R Hummel

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Emerging Role of Non-Coding RNAs in Esophageal Squamous Cell Carcinoma.International journal of molecular sciences · 2019
    Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 2 countries.

A K EichelmannDepartment of General and Visceral Surgery, University Hospital Münster, Albert-Schweitzer-Campus 1, W1, 48149, Münster, Germany. Ann-Kathrin.Eichelmann@ukmuenster.de.
C MatuszcakUniversity Cancer Center Hamburg, Department of Pneumology, Martinistrasse 52, 20246, Hamburg, Germany.
K LindnerSchön Klinik Hamburg Eilbek, Dehnhaide 120, 22081, Hamburg, Germany.
J HaierNordakademie, Koellner Chaussee 11, 25337, Elmshorn, Germany.ORCID http://orcid.org/0000-0002-1278-9438
D J HusseyDiscipline of Surgery, College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia.
R HummelDepartment of Surgery, University Hospital of Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.
Flinders University · AUNordakademie · DESchön Klinik Hamburg Eilbek · DEUniversity Cancer Center Hamburg · DEUniversity Hospital Münster · DEUniversity Hospital Schleswig-Holstein · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

miRNAs play a crucial role in cancer development and progression. However, results on the impact of miRNAs on drug sensitivity and tumor biology vary, and most studies to date focussed on either increasing or decreasing miRNA expression levels. Therefore, the current study investigated the role of different expression levels of miR-130a-3p and miR-148a-3p on drug resistance and tumor biology in four esophageal squamous cell carcinoma cell lines. Interestingly, up- and downregulation of both miRNAs significantly increased sensitivity towards chemotherapy. MiRNA modulation also reduced adherence and migration potential, and increased apoptosis rates. Target analyses showed that up- and downregulation of both miRNAs activated the apoptotic p53-pathway via increased expression of either BAX (miR-148a-3p) or Caspase 9 (miR-130a-3p). miR-148a-3p downregulation seemed to mediate its effects primarily via regulation of Bim rather than Bcl-2 levels, whereas we found the opposite scenario following miR-148a-3p upregulation. A similar effect was observed for miR-130a-3p regulating Bcl-2 and XIAP. Our data provide the first evidence that miRNA modulation in both directions may lead to similar effects on chemotherapy response and tumor biology in esophageal squamous cell carcinoma. Most interestingly, up- and downregulation seem to mediate their effects via modulating the balance of several validated or predicted targets.

Indexed as

Drug Resistance, NeoplasmCell Line, TumorEsophageal NeoplasmsEsophageal Squamous Cell CarcinomaHumansMicroRNAsNeoplasm ProteinsRNA, NeoplasmMicroRNAsMIRN130 microRNA, humanMIRN148 microRNA, humanNeoplasm ProteinsRNA, Neoplasm

Identifiers

PMID30510209
PMCPMC6277408
OpenAlexW2903219977

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.